Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease (AD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Georgetown University
Sponsor:
Information provided by (Responsible Party):
R. Scott Turner, Georgetown University
ClinicalTrials.gov Identifier:
NCT02947893
First received: October 21, 2016
Last updated: January 17, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Publications: